Around the world, innovative genomic-medicine programs capitalize on singular capabilities
arising from local health care systems, cultural or political milieus, and unusual selected risk …

Tuberculosis (TB) is one of the most devastating chronic infectious diseases, but the role of
host genetics in disease development after infection in this disease remains unidentified. …

β-Thalassemia/HbE disease is clinically variable. In searching for genetic factors modifying
the disease severity, patients were selected based on their disease severities, and a genome…

Objective Investigation of a possible involvement of differences in human leukocyte antigens
(HLA) in the risk of nevirapine (NVP)-induced skin rash among HIV-infected patients. …

Mycobacterium tuberculosis is considered by many to be the deadliest microbe, with the
estimated annual cases numbering more than 10 million. The bacteria, including …

Background Co-trimoxazole is a sulfonamide-containing antibiotic that is effective in the
treatment of several infections and for prophylaxis of Pneumocystis jiroveci pneumonia. This …

In response to the SARS-CoV-2 Delta variant, which partially escaped the vaccine-induced
immunity provided by two doses of vaccination with CoronaVac (Sinovac), the National …

BACKGROUND: Anti-tuberculosis drug-induced liver injury (AT-DILI) is one of the most
common forms of drug-induced liver injury (DILI) in high tuberculosis (TB) burden countries. …

Background Phenytoin is one of the most common causative drugs of several types of severe
cutaneous adverse reactions (SCAR) such as Stevens–Johnson syndrome (SJS), toxic …

Extraordinary advances in high throughput next generation sequencing (NGS) technology
and bioinformatics are the main thrust that transforms the current state of healthcare into the …